Brief: Godavari Biorefineries Says Sathgen Therapeutics Division Expands To U.S. With Launch Of Subsidiary
17/12/2025 12:38
Dec 17 (Reuters) - Godavari Biorefineries Ltd GODA.NS: SATHGEN THERAPEUTICS DIVISION EXPANDS TO U.S. WITH LAUNCH OF SUBSIDIARY Source text: ID:nBSE3SdM0C Further company coverage: GODA.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Godavari Biorefineries
See all newsIndia's Godavari Biorefineries at 2-month high after securing US patent for cancer treatment
Brief: Godavari Biorefineries Says US Patent Granted For Cancer Treatment Compound
Brief: Godavari Biorefineries Says Mexican Patent Office Grants Patent For Compounds Treating Viral Infections
India's Godavari Biorefineries jumps after securing Chinese patent
Brief: Godavari Biorefineries Says Chinese Patent Office Grants Patent For Use Of Compounds To Treat Viral Infections